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Objective: To evaluate the factors leading to the early onset of menopause (<40 years) in the women in the 
interior of Sindh. 
Materials and Methods: A cross-sectional study was conducted on 218 individuals among them 109 were 
postmenopausal women (with premature menopause)  and 109 were normal menstruating females during the 
period of six months from November 2014 to April  2015, data was obtained from Interior Sindh, Larkana, 
Hyderabad, and Benazirabad.  Factors considered were age, number of children, history of the obstetric process 
(ovarian and uterine), diseases, and premature menopause history in first-cousin marriages. The questionnaire 
data and blood samples were collected for hormonal assays such as LH,  prolactin, and FSH. The hormone levels 
were analyzed by ELISA method, SPSS version 17 was used for data analysis. 
Results:  Out of 109 subjects the percentage of early menopause due to: anorexia nervosa was 17%, brain tumor 
7%, ovarian cancer 6%, hormonal disorders 23%, hysterectomy 15%, oophorectomy 5%, Pituitary gland 
dysfunction 4%, Sheehan Syndrome 24%, Polycystic Ovarian Syndrome (PCOS) 8%. 
Conclusion: Early menopause was found related to pathological and psychological factors including brain tumor, 
ovarian cancer, family history, Anorexia nervosa, and certain surgical interventions. 
Keywords: Early menopause, ovarian cancer, family history, hormonal disturbance. 




The Word menopause is derived from the Greek word 
“meno” which means stop cease.  This is an aging 
process due to a reduction in the ovarian hormones 
progesterone and estrogen.1 The normal age of 
menopause is about 44-55 years, but some women 
suffer from menopause before 40 years of age. 
Menopause that occurs before 40 years of age, due to 
any reason, is called premature menopause. This can 
leads to earlier onset of chronic diseases of aging and 
therefore lengthen to later years as well.  Menopause is 
a major factor for bone degeneration.1-4  
Furthermore; premature or early menopause, also 
known as a premature ovarian failure (POF), is an 
important disorder that affects a significant population 
of young women.5 Characteristics of this condition are 
amenorrhea, elevated gonadotropins, and decreased 
gonadal steroids. The effect of this condition is on both 
physical and psychological components, it is so 
because of the long term effects of the gonadotrophin 
depletion in the body. Furthermore, the distressing 
result of this condition is infertility.6 Proper 
functioning of the hypothalamus, pituitary gland, 
uterus, and ovaries are necessary for the normal 
menstrual cycle. The hypothalamus triggers the 
pituitary gland; the pituitary stimulates follicle-
stimulating hormone (FSH) and luteinizing hormone 
(LH). FSH and LH trigger the ovaries to produce 
hormones estrogen and progesterone.7 Estrogens and 
androgens affect the skeleton during growth and 
skeletal homeostasis during adulthood. The decrease 
in estrogen concentration with menopause effects of 
female bone resorption.8 The study conducted in 
Jordanian women with early menopause shows that 
the association factor for the early menopause history 
in first-cousin marriages.1 Similar studies were carried 
out on early menopause and risk of fracture, 
osteoporosis, and mortality in Swedish women aged 
48 years with early menopause, later on at the age of 
77, they had a risk ratio of 1.83 for osteoporosis, for 
fragility fracture risk ratio was 1.68 and mortality risk 
was 1.59.9 
Premature menopause results in adverse effects, which 
include cardiovascular diseases, psychiatric diseases, 
mortality, neurological diseases, osteoporosis, 
Sheehan’s syndrome, and early death.10 Hormonal 
therapies have succeeded to moderate levels with 
some risks but many others are still under the line and 
faced by the patients.11,12 
This study was aimed to assess the factors which cause 
menopause at an early age and to check the prevalence 
of factors which are most common along with factors 
having raised FSH, LH & Prolactin levels and those 
having low FSH, LH & Prolactin levels in the women 
of Interior of Sindh as compared to the women of the 
same age without early menopause. Also, inform the 
healthcare personnel about the situation so that they 
may consider the prevailing factors while treating the 
patients. 
 
Materials and Methods 
 
A cross-sectional study, for which participants were 
selected from Interior Sindh. The duration of the study 
was about six months. A convenient non-probability 
technique has been used for sampling. The sample size 
was 218 subjects. Females with early menopause were 
included in the study as case, their age is 33.3 ± 3.23  
whereas women with normal menstrual cycles were 
included as controls for the study of age 32.67 + 3.07 
respectively. Females on medication and suffering 
from any disease particularly any hormonal disorder 
were excluded. Blood samples required for the study 
were collected from normal and affected individuals 
and written consent was obtained before the sampling. 
Samples were collected in 5ml gel tubes and serum 
was separated.   
The ELISA method was used to assess the 
concentration of Prolactin, LH, and FSH hormones13,14, 
in their blood by using Human diagnostic worldwide 
test kits with Elisa reader UVM 340. The principle is 
based on monoclonal antibodies and another in 
antibody-enzyme conjugate solution.  The sample is 
reacted with antibodies at the same time with 
antibodies resulting in the sandwiching of sample 
molecules between the solid phase and enzyme-linked 
antibodies. For this 100 µl of the conjugate is dispensed 
into the wells. 50 µl of calibrator was added into the 5 
wells.  50 µl of control & samples into the wells and 
then the plate is covered with an adhesive sheet and 
incubated at 37oc for about 60 minutes. The solution is 
then removed from the wells and was washed with a 
wash solution for any unbounded antibodies.  100 µl 
of the substrate was poured into the wells and was 
covered with aluminum foil and incubated for about 
15 minutes at room temperature and stop solution (100 
µl) is added into the wells for any further color 
development and finally, OD is observed at 450nm in 
a plate reader. 
All data obtained were put into SPSS version 17 for 
analysis of results. 
Ethical Consideration: The questionnaire was 
anonymously administered to the women/girls, with 
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the permission of the ethical review committee of the 
Department of Physiology. Written consents were 
taken from the control and subject groups before 
managing the questionnaires. The present study will 




In this study, 109 cases and 109 healthy controls were 
studied. From cases, 104 were housewives, and 5 were 
office workers. The mean age of the cases involved in 
this study was 33.3 ± 3.23 while controls 32.67 + 3.07. 
The mean FSH, LH, and PROLACTIN were higher in 
study cases than controls. The mean BMI value of 
controls was (24.14 + 3.78) and that of study cases was 
(23.78 + 4.56).  
In the case of Anorexia Nervosa (17%), the mean FSH 
level was lower in cases than in controls, similarly, the 
mean LH level of cases was lower than in controls. 
Whereas, the mean Prolactin level was higher in 
subjects than in controls. The results were significant 
as shown in table-1. 
In subjects of Brain Tumor (7%), the mean FSH level 
was higher than in the control; similarly, the mean LH 
levels were also higher in study subjects than in 
controls. The mean Prolactin level was also elevated in 
subjects as compared to controls. Women undergoing 
Ovarian Cancer (6%) have a mean FSH level, mean LH 
level, and mean Prolactin level increased than controls. 
In the case of Hormonal disorders (23%), the mean 
FSH level was greater in study subjects than controls, 
similarly the mean LH level and mean Prolactin level 
were also notable than controls. 
Post Hysterectomy (15%) cases had a high level of 
FSH, LH, and Prolactin as compared to the controls. In 
cases of Oophorectomy (5%) the mean FSH level, 
mean LH level and mean Prolactin level was higher 
than controls which herald early menopause. 
In the case of Pituitary Dysfunction (4%) the study 
subjects had a higher mean FSH level than in controls, 
similarly, the mean LH level of subjects was also 
higher than in controls and the mean Prolactin level 
was also at an elevated level in subjects than in 
controls. 
Similarly, in the case of Sheehan Syndrome, the cases 
had a greater mean FSH level mean LH level, and 
mean Prolactin level than controls. Women 
undergoing Polycystic Ovarian Syndrome (8%) had 












Table 1: Differences in FSH, LH, and Prolactin level in control & cases of early menopause in different 
conditions 
Different conditions Hormones        CASE CONTROL T-VALUE P-VALUE  
ANOREXIA NERVOSA FSH 7.79 + 1.95 10.8 + 1.66 4.85 <0.001 
LH 13.5 + 3.17 20.30 + 1.75 8.86 <0.001 
PRL 22.01 ± 2.13 11.34 ± 1.94 15.71 <0.001 
BRAIN TUMOR FSH 14.04 ± 3.88 10.94 ± 1.85 1.972 0.09 
LH  21.54 ± 5.21 21.05 ± 1.55 0.235 0.82 
PRL 27.41 ± 4.70 10.54 ± 1.88 9.631 <0.001 
OVARIAN CANCER FSH 40.4 ± 4.70 11.86 ± 1.04 13.60 <0.001 
LH 60.9 ± 5.93 21.1 ± 2.35 15.63 <0.001 
PRL 40.2 ± 10.07 13.25 ± 2.98 6.22 0.002 
HORMONAL 
DISORDER 
FSH 36.20 ± 6.97 10.21 ± 2.12 17 <0.001 
LH 45.82 ± 8.80 20.38 ± 3.18 15.63 <0.001 
PRL 33.62 ± 6.04 13.12 ± 2.33 16.9 <0.001 
HYSTERECTOMY FSH 32.74 ± 5.4 10.38 ± 2.38 13.9 <0.001 
LH 42.07 ± 6.73 20.41 ± 3.73 9.64 <0.001 
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PRL 30.54 ± 5.29 15.80 ± 4.33 6.87 <0.001 
OOPHORECTOMY FSH 34.48 ± 4.25 7.46 ± 1.08 13.21 <0.001 
LH 49.14 ± 9.77 17.26 ± 4.08 9.803 0.001 
PRL 26.48 ± 5.59 11.64 ± 1.54 6.904 0.002 
PITUITARY 
DYSFUNCTION 
FSH 46.00 ± 2.25  10.30 ± 2.34 35.94 <0.001 
LH 65.22 ± 4.25 20.92 ± 2.19 14.727 0.001 
PRL 40.95 ± 9.03 14.92 ± 3.31 6.643 0.007 
SHEEHAN SYNDROME FSH 38.40 ± 9.29 10.39 ± 2.30 14.284 <0.001 
LH 54.27 ± 8.90 20.38 ± 3.28 18.801 <0.001 
PRL 38.49 ± 9.78 13.22 ± 4.36 10.511 <0.001 
POLYCYSTIC  OVARIAN 
SYNDROME 
FSH 42.82 ± 3.37 10.81 ± 2.22 18.051 <0.001 
LH 57.42 ± 6.26 21.08 ± 2.69 19.019 <0.001 
PRL 41.87 ± 6.28 12.98 ± 2.80 12.832 <0.001 
ALL CASES FSH 31.35 ± 13.4 10.4 ± 2.13 15.780 <0.001 
LH 43.12 ± 17.3 20.39 ± 2.96 13.754 <0.001 
PRL 32.9 ± 9.26 13.08 ± 3.4 21.47 <0.001 
As shown in Table: 1; the serum FSH, LH, and Prolactin level is significantly higher in menopausal women (in 
Brain tumor, Ovarian cancer, hysterectomy, Oophorectomy, Polycystic ovarian syndrome and in pituitary 
disorders) as compared to normal menstruating females. 
 
Table 2: Differences in BMI in control & cases of early menopause in different conditions 
      BMI CASE CONTROL T-VALUE P-VALUE 
ANOREXIA 
NERVOSA 
25.94 ± 3.47 25.64 ± 3.92 1.000 0.332 
BRAIN 
TUMOR 
23.42 ± 4.27 23.3 ± 4.24 0.711 0.515 
OVARIAN 
CANCER 
23.0 ± 3.6 23.00 ± 3.68 1.147 0.289 
HORMONAL 
DISORDER 
25.43 ± 3.23 23.47 ± 3.95 0.2801 0.01 
 
HYSTERECTOMY 
25.3 ± 3.65 24.9 ± 3.78 1.000 0.334 
 
OOPHORECTOMY 
23.2 ± 2.28 23.1 ± 2.18 0.670 0.47 
PITUITARY 
DYSFUNCTION 
24.0 ± 2.82 22.50 ± 4.12 1.000 0.391 
SHEEHAN 
SYNDROME 





27.12 ± 2.79 24.62 ± 3.96 1.01 0.34 
ALL CASES 23.7 ± 4.56 24.14 ± 3.78 0.688 0.493 
As illustrated in table no.2 BMI was slightly fluctuating in both case and control groups however not reaching the 
significance level. BMI is not a factor causing the onset of early menopause. 
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Discussion 
 
Early menopause is linked with long term multiple 
health consequences including diabetes15 cardiac 
problems, psychiatric disturbances, neurological 
disorders, osteoporosis along with increased 
mortality.16,17 
However, the adverse effects could be minimizing by 
giving estrogen therapy but it is not much beneficial in 
treating all these health issues.16 
This study is in conformation with reflective study18 
where the trends of hysterectomy were studied in the 
rural tertiary level teaching hospitals in Northern 
India. It was concluded that early menopause is either 
impulsive or driven. Women suffering from 
menopause, because of bilateral hysterectomy, 
oophorectomy, or cancer treatment.19,20 This is all 
associated with early menopause. In contrast to this 
study, women with brain cancer had increased 
prolactin. The chances of infertility increase as a result 
of oncological treatment. It is postulated that 
chemotherapy and radiations used in cancer 
treatments lead to earlier menopause presented with 
much severe symptoms.21 In this study women who 
have undergone surgeries like hysterectomy and 
oophorectomy are nearly at increased risk of early 
menopause. Furthermore, a study conducted in USA 22 
also established that women undergoing surgeries 
have more risk for having early menopause.23,24 also 
conducted a similar study in women with and without 
hysterectomy. She also concluded that surgeries are 
related to earlier onset of menopause. 
Also the study on the Jordanian Women, 2010 shows 
that the women who suffered from early menopause 
were having a history of premature menopause in 
their parents, siblings or child1 furthermore it is 
reported that inheritance/genetic accounts for about 
25-30% in the onset of premature menopause cases.25 
Apart from the above-mentioned reasons one of the 
abnormalities of early menopause is the osteoporosis, 
estrogen depletion is linked with increased loss in 
bone mass and density, which results in approximately 
9 million cases of bone fractures per year all around 
the globe.26,27 conducted a study that reveals that early 
menopause was associated with low (BMI) which is 
also in confirmation with this study that both low and 
high BMI are causes of early menopause. Anorexia is 
also a sign of early menopause. The loss of weight is a 
ubiquitous feature of amenorrhea. It is reported that 
being underweight may speedup menopause.28 
Likewise a study also demonstrated the Anorexia 
Nervosa is one of the causes of amenorrhea leading to 
early onset of menopause.29 
There are certainly other contributing factors that 
result in early menopause, females with low parity or 
null parity are highly prevalent to premature/early 
menopause, likewise, females who experience early 
menarche are also at greater risk.30,31 Study conducted 
in the UK reported that twin females at higher risk of 
early menopause.32 Apart from genetics and 
physiological factors many social and lifestyle factors 
are also linked with early and immature menopause-
like cigarette smoking33,34 childhood malnutrition, 
emotional stress, and cognitive function during 




The study was conducted on a small population due to 
fewer resources, big sample size could portray a 
clearer picture of the story.  
            
Conclusion 
  
In the Interior of Sindh, women have symptoms of 
early menopause.  Results of the study revealed that 
there are many underlying causes of early menopause 
but the common factors observed were certain 
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